Phytochemicals as Novel Therapeutic Agents for Treating Chronic Diseases: Efficacy, Safety, and Clinical Considerations

Authors

  • Vishal Gajanan Murkute
  • Yogesh Vinayak Junghare
  • Mahesh P. Junghare
  • Laxman. S. Junghare

Keywords:

Anti-inflammatory effects, Cardiovascular diseases, Chronic diseases, Clinical considerations, Clinical trials development, Disease management, Metabolic disorders, Natural compounds, Phytochemicals, Plant-based medicine, Secondary metabolites, Therapeutic agents

Abstract

Phytochemicals, derived from plants, are increasingly recognized for their potential therapeutic benefits in managing chronic diseases. This review aims to assess their efficacy, safety, and clinical considerations. Phytochemicals exhibit diverse biological activities, including antioxidant, anti-inflammatory, and anticancer properties, which make them promising candidates for adjunctive therapy or preventive measures against chronic conditions. However, the efficacy of phytochemicals varies depending on factors such as dosage, bioavailability, and patient population. Safety concerns, including potential toxicity and interactions with medications, warrant careful evaluation and monitoring. Furthermore, clinical studies exploring the efficacy of phytochemicals in chronic disease management are essential for evidence-based recommendations. Despite promising preclinical findings, the translation of phytochemicals into clinical practice requires rigorous investigation to establish their effectiveness and safety profiles. Additionally, considerations such as standardization of formulations and regulatory aspects are crucial for ensuring quality and consistency in phytochemical-based therapeutics while phytochemicals are potential novel therapeutic agents for chronic diseases, further research is necessary to elucidate their optimal use and integration into clinical practice.

Published

2024-04-10